ARCHIVES

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 30 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Researchers Uncover Tumors Sensitive to Chemotherapy

January 25, 2013

Studies Are Demonstrating Effectiveness of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 5, 1974

Cancer center directors to develop blueprint for progress that’s “honest,” M.D. Anderson’s John Mendelsohn says.

November 23, 2005

Peer Review changes Urged By NIH Team Include Appeals

April 8, 1977

Senate Bill Would Authorize $1 Billion for NCI; House Version Senate Bill Would Authorize $1 Billion for NCI; House Version Approved

April 8, 1977

Cancer Death Rate Declines, Clark Tells Science Writers

April 8, 1977